Product Catalogue Available Now*
Explore Certest’s 2026 PCR Innovations
Abacus dx is excited to present Certest’s latest VIASURE catalogue, bringing new clinically relevant targets, updated respiratory panels, and broader coverage across GI, tropical diseases, AMR, and human genetics.
All new assays feature Certest’s signature advantages:
- Room‑temperature storage (lyophilised reagents)
- Long shelf life (up to 24 months)
- Unified thermal protocol across the entire menu
- Compatibility with major thermocyclers
- Fast, easy‑to‑use formats for routine diagnostics
What's New in 2026
Gastrointestinal
Sapovirus + Astrovirus + Rotavirus
Respiratory
- Measles + Rubella (RUO)
- Adenovirus (quantitative)
- RP06 / RP07 respiratory panels (NEW configurations)
Expanded coverage for seasonal and emerging respiratory pathogens.14 key respiratory pathogens in a single run, covering Flu A/B, RSV, SARS‑CoV‑2, seasonal coronaviruses, parainfluenza 1–4, adenovirus, metapneumovirus, bocavirus, and rhinovirus/enterovirus
Tropical & Vector‑Borne
- Mayaro & Oropouche
- Oropouche virus (NEW monoplex)
Antimicrobial Resistance
- Candida auris (RUO)
Human Genetics
- Fetal Sex Determination (RUO)
Detect Y-chromosome specific genes in fetal free circulating DNA isolated from maternal plasma (cell-free fetal DNA, or cffDNA)
Sexual Health
- Sexual Health panel SP02 (RUO)
Detection of DNA from 28 types of Human Papillomavirus (HPV)
Immunosupressed & Meningitis
- Hepatitis C virus (quantitative)
- Hepatitis D virus (quantitative)
- JC virus (quantitative)
